puma biotechnology announces

Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at

Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at

Filed under: San Antonio Drug Rehab Centers

The Phase II clinical trial of PB272 given in combination with the anticancer drug temsirolimus was conducted at Memorial Sloan-Kettering Cancer Center. The trial was supported by the National Comprehensive Cancer Network®, ASCO's Young Investigator …
Read more on Business Wire (press release)

 

Galena Biopharma Presents Final Landmark 60-Month Results From NeuVax

Filed under: San Antonio Drug Rehab Centers

The event is being held December 4-8, 2012 at the Henry B. Gonzalez Convention Center in San Antonio, Texas. "New treatment options are needed to address unmet medical needs for breast cancer patients with HER2 low-to-intermediate expression or IHC …
Read more on GlobeNewswire (press release)

 

South Africa makes progress in HIV/AIDS fight

Filed under: San Antonio Drug Rehab Centers

Two decades later the clinic is the biggest ARV (anti-retroviral) treatment center in the country and sees between 600 to 800 patients a day from all over southern Africa. Those who are brought in on wheelchairs, sometimes on the brink of death, get …
Read more on San Antonio Express